- Public Comps
- Athanase Innovation
Athanase Innovation Valuation Multiples
Discover revenue and EBITDA valuation multiples for Athanase Innovation and similar public comparables like Inversiones Union Espanola, Palmboomen Cultuur, Audacia, Accentis and more.
Athanase Innovation Overview
About Athanase Innovation
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
Founded
2016
HQ

Employees
43
Website
Sectors
Financials (FY)
EV
$4M
Valuation Multiples
Start free trialAthanase Innovation Financials
Athanase Innovation reported last fiscal year revenue of $5M and negative EBITDA of ($5M).
In the same fiscal year, Athanase Innovation generated ($1M) in gross profit, ($5M) in EBITDA losses, and had net loss of ($6M).
Athanase Innovation P&L
In the most recent fiscal year, Athanase Innovation reported revenue of $5M and EBITDA of ($5M).
Athanase Innovation is unprofitable as of last fiscal year, with gross margin of (26%), EBITDA margin of (100%), and net margin of (132%).
Financial data powered by Morningstar, Inc.
Athanase Innovation Stock Performance
Athanase Innovation has current market cap of $40M, and enterprise value of $4M.
Market Cap Evolution
Athanase Innovation's stock price is $2.13.
Athanase Innovation share price increased by 0.4% in the last year.
Athanase Innovation has an EPS (earnings per share) of $-0.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4M | $40M | 0.5% | -0.0% | 15.2% | 0.4% | $-0.32 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAthanase Innovation Valuation Multiples
Athanase Innovation trades at 0.8x EV/Revenue multiple, and (0.8x) EV/EBITDA.
Athanase Innovation Financial Valuation Multiples
As of September 5, 2026, Athanase Innovation has market cap of $40M and EV of $4M.
Athanase Innovation has a P/E ratio of (6.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Athanase Innovation Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Athanase Innovation Margins & Growth Rates
In the most recent fiscal year, Athanase Innovation reported gross margin of (26%), EBITDA margin of (100%), and net margin of (132%).
Athanase Innovation Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Athanase Innovation Operational KPIs
Athanase Innovation's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Athanase Innovation Competitors
Athanase Innovation competitors include Inversiones Union Espanola, Palmboomen Cultuur, Audacia, Accentis, Altus, WT Financial Group, Numulae Gestion De, RedFish LongTerm Capital, Acanthe Developpement and VBARE Iberian Properties.
Most Athanase Innovation public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 8.2x | - | 9.3x | - | |||
| - | - | - | - | |||
| 2.0x | 2.0x | 16.0x | 72.6x | |||
| 5.6x | - | 16.9x | - | |||
| 0.1x | - | 0.5x | - | |||
| 0.2x | - | 7.6x | - | |||
| 5.6x | - | 17.2x | - | |||
| 1.3x | - | 11.4x | - | |||
This data is available for Pro users. Sign up to see all Athanase Innovation competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Athanase Innovation
| When was Athanase Innovation founded? | Athanase Innovation was founded in 2016. |
| Where is Athanase Innovation headquartered? | Athanase Innovation is headquartered in Sweden. |
| How many employees does Athanase Innovation have? | As of today, Athanase Innovation has over 43 employees. |
| Is Athanase Innovation publicly listed? | Yes, Athanase Innovation is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Athanase Innovation? | Athanase Innovation trades under ATIN ticker. |
| When did Athanase Innovation go public? | Athanase Innovation went public in 2017. |
| Who are competitors of Athanase Innovation? | Athanase Innovation main competitors include Inversiones Union Espanola, Palmboomen Cultuur, Audacia, Accentis, Altus, WT Financial Group, Numulae Gestion De, RedFish LongTerm Capital, Acanthe Developpement, VBARE Iberian Properties. |
| What is the current market cap of Athanase Innovation? | Athanase Innovation's current market cap is $40M. |
| What is the current revenue of Athanase Innovation? | Athanase Innovation's last fiscal year revenue is $5M. |
| What is the current EV/Revenue multiple of Athanase Innovation? | Current revenue multiple of Athanase Innovation is 0.8x. |
| Is Athanase Innovation profitable? | No, Athanase Innovation is not profitable. |
| How many companies Athanase Innovation has acquired to date? | Athanase Innovation hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Athanase Innovation has invested to date? | Athanase Innovation hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Athanase Innovation
Lists including Athanase Innovation
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




